Figure 6
Figure 6. CD150 marks a population of more quiescent HSCs. SPKLS cells fractionated based on position within the SP (Hoechst Blue fluorescence) and CD150 expression (gates i-iv) were isolated from mice treated with the nucleotide analog BrdU for 3 days and examined by flow cytometry for BrdU incorporation, an indicator of transition through the cell cycle. CD150− SPKLS cells were substantially more proliferative in vivo than their CD150+ SPKLS counterparts, with the lower SP being generally less in cell cycle than the upper SP. Percentages shown correspond to the gated proportion of the plot.

CD150 marks a population of more quiescent HSCs. SPKLS cells fractionated based on position within the SP (Hoechst Blue fluorescence) and CD150 expression (gates i-iv) were isolated from mice treated with the nucleotide analog BrdU for 3 days and examined by flow cytometry for BrdU incorporation, an indicator of transition through the cell cycle. CD150 SPKLS cells were substantially more proliferative in vivo than their CD150+ SPKLS counterparts, with the lower SP being generally less in cell cycle than the upper SP. Percentages shown correspond to the gated proportion of the plot.

Close Modal

or Create an Account

Close Modal
Close Modal